BIOCON
Quarterly Results Analysis [Mar2025]
BIOCON Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹4,417 Cr | ₹3,821 Cr | ₹3,590 Cr | ₹3,433 Cr | ₹3,917 Cr | ₹3,954 Cr | ₹3,462 Cr | ₹3,423 Cr |
Expenses | ₹3,339 Cr | ₹3,070 Cr | ₹2,905 Cr | ₹2,813 Cr | ₹3,001 Cr | ₹3,027 Cr | ₹2,721 Cr | ₹2,708 Cr |
Operating Income | ₹1,078 Cr | ₹752 Cr | ₹685 Cr | ₹620 Cr | ₹916 Cr | ₹927 Cr | ₹742 Cr | ₹714 Cr |
Other Income | ₹37 Cr | ₹35 Cr | ₹33 Cr | ₹1,135 Cr | ₹49 Cr | ₹566 Cr | ₹158 Cr | ₹94 Cr |
Interest | ₹212 Cr | ₹223 Cr | ₹226 Cr | ₹236 Cr | ₹227 Cr | ₹267 Cr | ₹248 Cr | ₹233 Cr |
Depreciation | ₹436 Cr | ₹425 Cr | ₹420 Cr | ₹405 Cr | ₹407 Cr | ₹415 Cr | ₹389 Cr | ₹358 Cr |
Profit Before Tax | ₹487 Cr | ₹156 Cr | ₹98 Cr | ₹1,146 Cr | ₹322 Cr | ₹832 Cr | ₹239 Cr | ₹217 Cr |
Profit After Tax | ₹459 Cr | ₹81 Cr | ₹27 Cr | ₹862 Cr | ₹226 Cr | ₹777 Cr | ₹197 Cr | ₹182 Cr |
EPS | ₹2.87 | ₹0.21 | ₹-0.13 | ₹5.49 | ₹1.13 | ₹5.50 | ₹1.05 | ₹0.84 |
Industry Peers & Returns | 1W | 1M | 1Y |
BIOCON | 2.8% | 6.7% | 4.5% |
SUN PHARMACEUTICAL INDUSTRIES | 0.6% | -0.4% | 4.7% |
DIVIS LABORATORIES | -2.2% | 1.7% | 47.3% |
CIPLA | -0.2% | -1.4% | -1.9% |
TORRENT PHARMACEUTICALS | 2.5% | 4.8% | 12.2% |
DR REDDYS LABORATORIES | -2.6% | -8.1% | -4.9% |
MANKIND PHARMA | 11.1% | 13.3% | 19.9% |
ZYDUS LIFESCIENCES | -1.5% | -0.7% | -17% |
LUPIN | 0.2% | -3.8% | 3.6% |
BIOCON Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 15.59 % |
Y-o-Y | 12.76 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹4,417 Cr | 15.59 | |
Dec2024 | ₹3,821 Cr | 6.43 | |
Sep2024 | ₹3,590 Cr | 4.59 | |
Jun2024 | ₹3,433 Cr | -12.36 | |
Mar2024 | ₹3,917 Cr | -0.93 | |
Dec2023 | ₹3,954 Cr | 14.19 | |
Sep2023 | ₹3,462 Cr | 1.16 | |
Jun2023 | ₹3,423 Cr | - |
BIOCON Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 43.42 % |
Y-o-Y | 17.72 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹1,078 Cr | 43.42 | |
Dec2024 | ₹752 Cr | 9.69 | |
Sep2024 | ₹685 Cr | 10.48 | |
Jun2024 | ₹620 Cr | -32.26 | |
Mar2024 | ₹916 Cr | -1.18 | |
Dec2023 | ₹927 Cr | 24.97 | |
Sep2023 | ₹742 Cr | 3.81 | |
Jun2023 | ₹714 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 24.10 % |
Y-o-Y | 4.41 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 24.41% | 24.10 | |
Dec2024 | 19.67% | 3.04 | |
Sep2024 | 19.09% | 5.64 | |
Jun2024 | 18.07% | -22.71 | |
Mar2024 | 23.38% | -0.26 | |
Dec2023 | 23.44% | 9.43 | |
Sep2023 | 21.42% | 2.64 | |
Jun2023 | 20.87% | - |
BIOCON Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 466.46 % |
Y-o-Y | 103.63 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹459 Cr | 466.46 | |
Dec2024 | ₹81 Cr | 199.26 | |
Sep2024 | ₹27 Cr | -96.86 | |
Jun2024 | ₹862 Cr | 282.00 | |
Mar2024 | ₹226 Cr | -70.98 | |
Dec2023 | ₹777 Cr | 294.82 | |
Sep2023 | ₹197 Cr | 8.13 | |
Jun2023 | ₹182 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 390.57 % |
Y-o-Y | 80.56 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 10.4 % | 390.57 | |
Dec2024 | 2.12 % | 182.67 | |
Sep2024 | 0.75 % | -97.01 | |
Jun2024 | 25.1 % | 335.76 | |
Mar2024 | 5.76 % | -70.70 | |
Dec2023 | 19.66 % | 245.52 | |
Sep2023 | 5.69 % | 6.95 | |
Jun2023 | 5.32 % | - |
BIOCON Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 1,266.67 % |
Y-o-Y | 153.98 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹2.87 | 1,266.67 | |
Dec2024 | ₹0.21 | Positive | |
Sep2024 | ₹-0.13 | Negative | |
Jun2024 | ₹5.49 | 385.84 | |
Mar2024 | ₹1.13 | -79.45 | |
Dec2023 | ₹5.5 | 423.81 | |
Sep2023 | ₹1.05 | 25.00 | |
Jun2023 | ₹0.84 | - |
You may also like the below Video Courses